CVS Health (CVS)
(Delayed Data from NYSE)
$57.32 USD
-0.08 (-0.14%)
Updated May 21, 2024 04:00 PM ET
After-Market: $57.30 -0.02 (-0.03%) 7:58 PM ET
5-Strong Sell of 5 5
A Value A Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$57.32 USD
-0.08 (-0.14%)
Updated May 21, 2024 04:00 PM ET
After-Market: $57.30 -0.02 (-0.03%) 7:58 PM ET
5-Strong Sell of 5 5
A Value A Growth C Momentum A VGM
Zacks News
Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.
Fred's (FRED) Sluggish Store Sales Keep Investors at Bay
by Zacks Equity Research
Fred's (FRED) continues to witness dismal comps and store closures. Also, cancelled dividend and merger deal make this retailer a less-favored pick.
5 Reasons Why McKesson Deserves a Place in Your Portfolio
by Zacks Equity Research
McKesson (MCK) continues to pursue deals, divestitures and acquisitions to drive growth. The company's impressive performance in 2017 accounts for its potential to sustain the momentum.
Company News For January 5, 2018
by Zacks Equity Research
Companies In The News are:
CVS Health's (CVS) Outlook for 2018 Cheered by Investors
by Zacks Equity Research
CVS Health (CVS) to witness increased cash flow of around $1.2 billion in 2018, courtesy the latest US Tax legislation.
Fred's Tanks 79% in a Year: Any Chances of Revival Ahead?
by Zacks Equity Research
Fred's (FRED) has been struggling with its dismal comps performance stemming from receding traffic and store closures. Also, management cancelled its quarterly dividend recently.
Declining Comps Likely to Hurt Fred's (FRED) in Q3 Earnings
by Zacks Equity Research
Fred's (FRED) third-quarter fiscal 2017 performance is expected to be hurt by dismal comps trend.
Company News For Nov 7, 2017
by Zacks Equity Research
Companies In The News are: ON,BRK.B,S,TMUS,CVS
McKesson (MCK) to Acquire RxCrossroads for $735 Million
by Zacks Equity Research
McKesson's (MCK) acquisition of RxCrossroads will boost its Specialty Health business.
CVS Health (CVS) Beats On Q3 Earnings, Revenues In Line
by Zacks Equity Research
CVS Health (CVS) witnesses year over year growth in Pharmacy Services segment in Q3.
Is a CVS Health (CVS) - Aetna (AET) Deal in the Cards?
by Arpita Dutt
Is an e-commerce company's interest in entering the drug pharmacy space the reason behind CVS Health's (CVS) interest in acquiring Aetna?
Rite Aid (RAD) Slumps 14% Since Q2 Loss: What Lies Ahead?
by Zacks Equity Research
Rite Aid Corporation (RAD), which had quite an eventful journey of late, reported dismal second-quarter fiscal 2018 results last week. However, latest deal with Walgreens should benefit.
Can Fred's Strategies Help It Counter Slow Comps & Traffic?
by Zacks Equity Research
Fred's (FRED) has been struggling with declining store traffic and sluggish comps over the past few quarters. The company has been focusing on cost reduction and internal restructuring.
What FTC's Curtail on RAD Store Purchase Means for Walgreens?
by Zacks Equity Research
Walgreens' (WBA) purchase of lesser number of Rite Aid stores upsets investors. Let's draw an insight from this.
Rite Aid Gets FTC Nod for Sale of Fewer Stores to Walgreens
by Zacks Equity Research
After four amendments, Rite Aid Corp. (RAD) and Walgreens Boots Alliance Inc. (WBA) finally received a nod for the fresh proposal the latter put forward yesterday.
Why Did Rite Aid (RAD) Stock Crash Today?
by Ryan McQueeney
Shares of Rite Aid (RAD) fell more than 10% on Tuesday after Walgreens Boots (WBA) received government approval to buy fewer Rite Aid stores than had initially been proposed.
Walgreens to Revisit Rite Aid Deal for Antitrust Approval
by Zacks Equity Research
The Federal Trade Commission ("FTC") seems to be getting harsher on drugstore chains Walgreens Boots Alliance Inc. (WBA) and Rite Aid Corp. (RAD), which have been trying to appease the regulatory body since its initial merger pact in 2015.
The Zacks Analyst Blog Highlights: Disney, Kraft Heinz and CVS Health, Intercontinental Exchange and Ventas
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Disney, Kraft Heinz and CVS Health, Intercontinental Exchange and Ventas
Tobacco Stocks in Focus as Cigarette Prices Rise in New York
by Zacks Equity Research
The news of cigarette price hike in New York City and other legislations to reduce the number of smokers have raised concerns of accelerated sales declines for traditional cigarettes.
What You Should Know About Fred's Apart From Dismal Comps
by Zacks Equity Research
Fred's (FRED) is yet to recover from the cancelled Walgreens-Rite Aid merger. The company has also been struggling with declining sales owing to lower comps and store closures.
Investors Are Keeping An Eye On Q2 Earnings
by Zacks Equity Research
Investors Are Keeping An Eye On Q2 Earnings
Q2 Earnings Rundown: KORS, RL, CVS & More
by Mark Vickery
The S&P 500 and Dow both hit new record highs yesterday, but are down marginally in today's pre-market.
CVS Health Beats on Q2 Earnings and Revenue Estimates
by Zacks Equity Research
CVS Health(CVS) rides high on Pharmacy Services segment in Q2.
Rite Aid Seems the Forbidden Fruit, Stock Down 20% in July
by Zacks Equity Research
Ever since Rite Aid Corp.'s (RAD) merger deal with Walgreens Boots Alliance Inc. (WBA) fell through on Jun 29, the stock has turned in to a forbidden fruit for investors.
Fred's Posts Dismal Comparable June Store Sales, Stock Down
by Zacks Equity Research
Fred's, (FRED), which has been struggling to recover from the blow of a failed merger between Rite Aid Corporation (RAD) and Walgreens Boots Alliance (WBA), recently announced soft June comparable store sales.
Fred's Stock Falls, Walgreens & Rite Aid Merger Deal Revised
by Zacks Equity Research
Fred's, Inc. (FRED) or Fred's Pharmacy lost over 20% yesterday after Walgreens Boots Alliance, Inc. (WBA) decided not to proceed with its planned takeover of the rival drugstore Rite Aid Corporation (RAD) due to various antitrust issues, as per Bloomberg. The cancelled merger significantly hurt Rite Aid???s stock too, which fell 26.46% yesterday.